WILLEMSE NORMAN
Known title: President Metal FormingCIK: 0001420140
Associated companies
Transaction History
| DCH | ▼ Sell | Tax Withholding | 47,085 | $354K | 3/17/2023 | View on chart |
| DCH | ▼ Sell | Other | 59,394 | $0 | 3/17/2023 | View on chart |
| DCH | ▲ Buy | Grant | 37,796 | $0 | 3/17/2023 | View on chart |
| DCH | ▲ Buy | Grant | 128,369 | $1.2M | 3/6/2023 | View on chart |
| DCH | ▼ Sell | Tax Withholding | 55,969 | $514K | 3/6/2023 | View on chart |
| DCH | ▼ Sell | Tax Withholding | 43,897 | $403K | 3/6/2023 | View on chart |
| DCH | ▼ Sell | Open Market | 59,265 | $533K | 2/22/2023 | View on chart |
| DCH | ▼ Sell | Tax Withholding | 9,447 | $75K | 3/4/2022 | View on chart |
| DCH | ▲ Buy | Grant | 64,795 | $600K | 2/28/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Dauch names new CFO, faces lower price targets from Barclays and UBS
Dauch Corporation announced a financial leadership change, appointing Nathan Iles as CFO effective December 1 to succeed Christopher May. This executive shift coincides with recent analyst actions, as both Barclays and UBS lowered their price targets to $8 while maintaining their respective ratings. The stock has experienced a significant decline since February, currently trading near its 52-week low, which has prompted discussions about potential undervaluation despite the recent downward revisions.
Dauch names new CFO, faces lower price targets from Barclays and UBS. Dauch Corporation announced a financial leadership change, appointing Nathan Iles as CFO effective December 1 to succeed Christopher May. This executive shift coincides with recent analyst actions, as both Barclays and UBS lowered their price targets to $8 while maintaining their respective ratings. The stock has experienced a significant decline since February, currently trading near its 52-week low, which has prompted discussions about potential undervaluation despite the recent downward revisions.